Attitudes of pregnant women in the Dominican Republic towards a future maternal Group B Streptococcus vaccine.

INTRODUCTION: Current protocols aim to prevent some infant GBS infection through screening and peripartum antibiotics, however such strategies cannot be widely implemented in resource-limited settings. On the other hand, maternal vaccines in development against Group B Streptococcus (GBS) can provide a feasible universal approach. The success of any vaccine will depend on uptake in the population. Rates of maternal GBS colonization in the Dominican Republic (DR) and Caribbean region are among the highest in the world, but little is known about attitudes towards maternal vaccines in this region. METHODS: A cross-sectional, multicenter, mixed-methodology survey evaluated facilitators and barriers to maternal immunization and acceptability of a hypothetical Group B Streptococcus vaccine among pregnant women in three hospitals in the DR. RESULTS: Six-hundred and fifty women completed the survey of whom 85 % had never heard of GBS. Following receipt of information about GBS and a vaccine, 94 % of women stated that they would be likely or very likely to receive a vaccine. Being 18 years or younger was associated with a lower likelihood of GBS vaccine receipt (AOR 0.32, 95 % CI 0.14-0.69). Being born in the DR was associated with a higher likelihood of GBS vaccine receipt (AOR 2.73, 95 % CI 1.25-5.97). Among women who were unlikely to receive the vaccine, uncertainty about potential harm from a novel vaccine was the prominent theme elicited from free text responses. CONCLUSION: There was a high level of acceptance of a future GBS vaccine among this sample of pregnant women in the DR. However, knowledge of vaccines and vaccine-preventable diseases was low, and most women had concerns about the safety of new vaccines. Interventions that strengthen existing maternal immunisation infrastructures, including increasing education of pregnant women about vaccines, will aid the successful implementation of a future GBS vaccine.

Vaccines for Streptococcus agalactiae: current status and future perspectives.

A maternal vaccine to protect newborns against invasive Streptococcus agalactiae infection is a developing medical need. The vaccine should be offered during the third trimester of pregnancy and induce strong immune responses and placental transfer of protective antibodies. Polysaccharide vaccines against S. agalactiae conjugated to protein carriers are in advanced stages of development. Additionally, protein-based vaccines are also in development, showing great promise as they can provide protection regardless of serotype. Furthermore, safety concerns regarding a new vaccine are the main barriers identified. Here, we present vaccines in development and identified safety, cost, and efficacy concerns, especially in high-need, low-income countries.

Testing Novel Inactivation Methods and Adjuvants for Vaccines Against Streptococcus agalactiae in Nile Tilapia Oreochromis niloticus.

Inactivation by hydrogen peroxide and pH manipulation are two novel methods used recently in experimental vaccines against Streptococcus agalactiae in Nile tilapia. Here we describe in detail inactivation using novel methods as well as the classical method of inactivation. These vaccines showed similar moderate efficacy when compared to the conventional formaldehyde vaccine. In addition, we describe the inclusion of adjuvants in a hydrogen peroxide vaccine.

Efficacy of two adjuvants administrated with a novel hydrogen peroxide-inactivated vaccine against Streptococcus agalactiae in Nile tilapia fingerlings.

Streptococcus agalactiae is considered the main bacterial pathogen in cultured Nile tilapia. Formaldehyde-inactivated vaccines are the most accepted method for prevention and control of the disease. However, alternative inactivation methods for S. agalactiae vaccines have not been fully explored. Recently, we developed a hydrogen peroxide-inactivated vaccine against S. agalactiae with moderate efficacy, with the possibility to improve vaccine efficacy by adding adjuvants. The current study compared the efficacy of aluminum hydroxide and Freund's incomplete adjuvant (FIA) incorporated into a novel hydrogen peroxide-inactivated intraperitoneal vaccine against S. agalactiae for Nile tilapia fingerlings. The relative percentage survival (RPS) for aluminum hydroxide-adjuvanted vaccine (59.3%), and FIA-adjuvanted vaccine (77.8%) were higher than the vaccine without adjuvant (40.7%). In addition, fish immunized with aluminum hydroxide-adjuvanted vaccine had significantly higher levels of specific antibodies than control fish at 4 weeks post vaccination (wpv). Blood lymphocytes counts showed a decrease in vaccinated groups when compared to control fish, suggesting white cells migration to the tissues where antigen presentation is ongoing. Fish that received FIA-adjuvanted vaccine exhibited persistence of adjuvant deposits on intraperitoneal surfaces for at least 4 wpv that may be related to its superior performance compared to aluminum hydroxide adjuvanted vaccine, which did not evidence any type of deposit at any sampling times. The results observed in this study demonstrate that hydrogen peroxide-inactivated vaccine administered with either aluminum hydroxide or FIA induce optimal levels of protection, with a superior performance for FIA vaccine, which could be a good alternative to conventional formaldehyde-inactivated vaccines against S. agalactiae, due to its shorter manufacture time, and less toxicity.

Economic appraisal of vaccination against Streptoccocus agalactiae in Nile tilapia farms in Brazil.

Infection with Streptococcus agalactiae causes mortality and major economic losses in Nile tilapia (Oreochromis niloticus) farming worldwide. In Brazil, serotype strains Ia, Ib and III have been isolated in streptococcosis outbreaks, but serotype Ib is the most prevalent. Vaccination is considered an effective method to prevent economically-important diseases in aquaculture and has been associated with decreased use of antibiotics and improvements in fish survival. We developed a flexible partial-budget model to undertake an economic appraisal of vaccination against Streptococcus agalactiae in Nile tilapia farmed in net cages in large reservoirs. The model considers the benefits and costs that are likely to be associated with vaccination at the farm-level, in one production cycle. We built three epidemiological scenarios of cumulative mortality attributable to S. agalactiae (5%, 10%, and 20%, per production cycle) in a non-vaccinated farm. For each scenario, we applied a stochastic model to simulate the net return of vaccination, given a combination of values of "vaccine efficacy", "gain in feed conversion ratio", "feed price", "fish market price ", and "cost of vaccine dose". In the 20% cumulative mortality scenario, the net return would break-even (benefits ≥ costs) in at least 97.9% of interactions. Should cumulative mortality be lower than 10%, the profitability of vaccination would be more dependent on better feed conversion ratio. The inputs "feed price" and "cost of vaccine" had minor effects on the output, in all pre-vaccination mortality scenarios. Although our simulations are based on conservative values and consider uncertainty about the modeled parameters, we conclude that vaccination against S. agalactiae is likely to be profitable in Nile tilapia farms, under similar production conditions.

Caracterização da microbiota vaginal, intestinal e oral durante o período gestacional / Vaginal, gut and oral microbiota characterization during pregnancy

A simbiose desenvolvida entre seres vivos e microrganismos desempenha um importante papel na relação saúde-doença do hospedeiro. Neste sentido, o corpo humano abriga uma grande e diversa comunidade de microrganismos, sendo as mucosas vaginal, intestinal e oral as principais superfícies mucosas do corpo feminino que abrigam as comunidades bacterianas de fundamental importância para a mulher. Estes microrganismos atuam no desenvolvimento e modulação do sistema imune, na manutenção e otimização de vias metabólicas e competem por sítios de colonização, prevenindo que microrganismos patogênicos estabeleçam colonização. A composição da microbiota feminina varia com a idade, pH, secreção hormonal, ciclo menstrual, uso de anticoncepcional e atividade sexual. O presente estudo buscou caracterizar a composição da microbiota do corpo feminino durante o período gestacional, comparando os achados entre gestantes e não gestantes saudáveis, através de técnicas de biologia molecular. Foram selecionadas 60 mulheres saudáveis para o estudo e coletadas amostras de secreção vaginal, fezes e swab oral de cada participante. O DNA das amostras foi extraído e submetido à sequenciamento do gene 16S rRNA e quantificado através da técnica de PCR em tempo real. Das participantes selecionadas, 42 eram gestantes e 18 eram mulheres não gestantes em idade reprodutiva. Observamos que a quantificação total de bactérias na vagina não apresentou diferenças entre gestantes e não gestantes. Houve aumento na abundância de Lactobacillus no sítio vaginal, bactérias produtoras de butirato na microbiota intestinal e Streptococcus na microbiota oral de mulheres grávidas quando comparadas com mulheres não gestantes. Além disso, observamos que a composição e a disposição dos gêneros encontrados sofrem uma modificação, tal como aumento de gêneros relacionados com a manutenção da homeostase no grupo de mulheres gestantes. O período gestacional influencia positivamente na composição da microbiota, garantindo assim a prevalência de gêneros bacterianos responsáveis pela manutenção das condições ideais para o desenvolvimento da gestação saudável

The symbiosis developed between living organisms and microorganisms plays an important role in the health-disease relationship of the host. In this sense, the human body harbor a large and diverse community of microorganisms, the vaginal, intestinal and oral mucosa are the main mucosal surfaces of the female body that harbor bacterial communities of fundamental importance for women. These microorganisms act in the development and modulation of the immune system, in the maintenance and optimization of metabolic pathways and compete for colonization sites, preventing pathogenic microorganisms from establishing colonization. The composition of the female microbiota varies with age, pH, hormonal secretion, menstrual cycle, contraceptive use and sexual activity. The present study aimed to characterize the microbiota composition of the female body during the gestational period, comparing the findings between healthy and non - pregnant women through molecular biology techniques. Sixty healthy women were selected for the study and samples of vaginal secretion, stool and oral swab from each participant were collected. The DNA of the samples was extracted and submitted to the 16S rRNA gene sequencing and quantified by the real-time PCR technique. Were select, 42 were pregnant and 18 were non-pregnant women of reproductive age. We observed that the total quantification of bacteria in the vaginal samples did not present differences between pregnant and non-pregnant women. There was an increase in the abundance of Lactobacillus in the vaginal site, butyrate producing bacteria in the intestinal microbiota and Streptococcus in the oral microbiota of pregnant women when compared to nonpregnant women. In addition, we observed that the composition and arrangement of the genera found undergo a modification, such as an increase in genera related to the maintenance of homeostasis in the group of pregnant women. The pregnancy influences the composition of the microbiota, thus ensuring the prevalence of bacterial genera responsible for the maintenance of the ideal conditions for the development of healthy pregnancy

Oral vaccine based on a surface immunogenic protein mixed with alum promotes a decrease in Streptococcus agalactiae vaginal colonization in a mouse model.

The Surface Immunogenic Protein (SIP) of Group B Streptococcus (GBS) had been described as a good target for vaccine development. To date, SIP has been reported as a highly conserved protein, and in a mouse model it induces protection against lethal GBS challenge. Also, similar effects have been described by intranasal immunization with a SIP-based vaccine. In this study, we show the immune response induced by an oral SIP-based vaccine formulated on alum in a mouse model. Our vaccine can reduce vaginal GBS colonization and induce specific SIP-antibodies with opsonophagocytosis activities against GBS. Moreover, we observed the activation of T-cells producing IFN-γ, TNF-α, IL-10, IL-2, and increased expression of the transcription factor T-bet, suggesting a Th1-type humoral response. The oral SIP-based vaccine is a novel alternative in the development of a vaccine against GBS.

Morphometric, bromatological, and sensory analysis of Nile tilapia vaccinated against Streptococcus agalactiae / Análise morfométrica, bromatológica e sensorial de tilápia do Nilo vacinada contra Streptococcus agalactiae

The objective of this study was to evaluate the effect of vaccination against Streptococcus agalactiae on the morphometry, bromatology, and sensory traits of tilapia bred in net-tanks. Tilapia juveniles were bred in net-tanks separated into two groups: vaccinated and unvaccinated fish. Ten fish from each group were collected from different weight classes: 400-500, 501-600, 601-700, and 701-800 g. Measurements and weighing of whole fish and fillets did not show significant differences between the two groups. Fillet thickness was significantly greater in unvaccinated fish in the weight range of 601-700 g. Significant differences were not found in protein, lipid, ash, or moisture content between the two groups in any of the weight classes studied. Significant preferences between unvaccinated and vaccinated fish were not observed in the paired preference test, regardless of weight class. The hedonic scale analysis showed that tasters moderately liked the tilapia fillets regardless of weight class or whether the fish had been vaccinated. In net-tank breeding experimental conditions, vaccinated and unvaccinated Nile tilapia weighing between 400 and 800 g showed similar morphometric, bromatological, and sensory characteristics.(AU)

O objetivo desse trabalho foi avaliar o efeito da vacinação contra Streptococcus agalactiae na morfometria, bromatologia e análise sensorial de tilápia criada em tanque-rede. Juvenis de tilápia foram criadas em tanque-rede separados em dois grupos: peixes vacinados e não vacinados. Foram coletados 10 peixes de cada grupo em diferentes classes de peso: 400-500, 501-600, 601-700 e 701-800 g. As medidas e pesagens do peixe inteiro e do filé não apresentaram diferença significativa entre os dois grupos. A espessura do filé foi significativamente maior nos peixes não vacinados na faixa de 601-700 g. Não teve diferença significativa nos valores de proteína, lipídio, cinza e umidade entre os peixes dos dois grupos em nenhuma das classes de peso estudada. Para o teste pareado preferência, não houve uma preferência significativa entre peixes não vacinados e vacinados independente da classe de peso analisada. A análise de escala hedônica apontou que os provadores gostaram moderadamente do filé de tilápia independente da classe de peso e de ter sido vacinado ou não. Nas condições experimentais de criação em tanques-rede, tilápias do Nilo vacinados e não vacinados, com peso entre 400 e 800 g, apresentaram características morfométricas, bromatológicas e sensoriais semelhantes.(AU)

Morphometric, bromatological, and sensory analysis of Nile tilapia vaccinated against Streptococcus agalactiae / Análise morfométrica, bromatológica e sensorial de tilápia do Nilo vacinada contra Streptococcus agalactiae

The objective of this study was to evaluate the effect of vaccination against Streptococcus agalactiae on the morphometry, bromatology, and sensory traits of tilapia bred in net-tanks. Tilapia juveniles were bred in net-tanks separated into two groups: vaccinated and unvaccinated fish. Ten fish from each group were collected from different weight classes: 400-500, 501-600, 601-700, and 701-800 g. Measurements and weighing of whole fish and fillets did not show significant differences between the two groups. Fillet thickness was significantly greater in unvaccinated fish in the weight range of 601-700 g. Significant differences were not found in protein, lipid, ash, or moisture content between the two groups in any of the weight classes studied. Significant preferences between unvaccinated and vaccinated fish were not observed in the paired preference test, regardless of weight class. The hedonic scale analysis showed that tasters moderately liked the tilapia fillets regardless of weight class or whether the fish had been vaccinated. In net-tank breeding experimental conditions, vaccinated and unvaccinated Nile tilapia weighing between 400 and 800 g showed similar morphometric, bromatological, and sensory characteristics.

O objetivo desse trabalho foi avaliar o efeito da vacinação contra Streptococcus agalactiae na morfometria, bromatologia e análise sensorial de tilápia criada em tanque-rede. Juvenis de tilápia foram criadas em tanque-rede separados em dois grupos: peixes vacinados e não vacinados. Foram coletados 10 peixes de cada grupo em diferentes classes de peso: 400-500, 501-600, 601-700 e 701-800 g. As medidas e pesagens do peixe inteiro e do filé não apresentaram diferença significativa entre os dois grupos. A espessura do filé foi significativamente maior nos peixes não vacinados na faixa de 601-700 g. Não teve diferença significativa nos valores de proteína, lipídio, cinza e umidade entre os peixes dos dois grupos em nenhuma das classes de peso estudada. Para o teste pareado preferência, não houve uma preferência significativa entre peixes não vacinados e vacinados independente da classe de peso analisada. A análise de escala hedônica apontou que os provadores gostaram moderadamente do filé de tilápia independente da classe de peso e de ter sido vacinado ou não. Nas condições experimentais de criação em tanques-rede, tilápias do Nilo vacinados e não vacinados, com peso entre 400 e 800 g, apresentaram características morfométricas, bromatológicas e sensoriais semelhantes.

Purinergic signaling modulates the cerebral inflammatory response in experimentally infected fish with Streptococcus agalactiae: an attempt to improve the immune response.

Appropriate control of the immune response is a critical determinant of fish health, and the purinergic cascade has an important role in the immune and inflammatory responses. This cascade regulates the levels of adenosine triphosphate (ATP), adenosine diphosphate, adenosine monophosphate and adenosine (Ado), molecules involved in physiological or pathological events as inflammatory and anti-inflammatory mediators. Thus, the aim of this study was to evaluate whether purinergic signaling, through the activities of nucleoside triphosphate diphosphohydrolase (NTPDase), 5'-nucleotidase, and adenosine deaminase (ADA), is capable of modulating the cerebral immune and inflammatory responses in silver catfish that is experimentally infected with Streptococcus agalactiae. Cerebral NTPDase (with ATP as substrate) and 5'-nucleotidase activities increased, while ADA activity decreased in silver catfish that is experimentally infected with S. agalactiae, compared to the control group. Moreover, the cerebral levels of ATP and Ado increased in infected animals compared to the uninfected control group. Brain histopathology in infected animals revealed inflammatory demyelination (the presence of occasional bubbly collections), increased cellular density in the area near to pia-mater and intercellular edema. Based on this evidence, the modulation of the purinergic cascade by the enzymes NTPDase, 5'-nucleotidase, and ADA exerts an anti-inflammatory profile due to the regulation of ATP and Ado levels. This suggests involvement of purinergic enzymes on streptococcosis pathogenesis, through regulating cerebral ATP and Ado levels, molecules known to participate in physiological or pathological events as inflammatory and anti-inflammatory mediators, respectively. In summary, the modulation of the cerebral purinergic cascade exerts an anti-inflammatory profile in an attempt to reduce inflammatory damage.

Involvement of cholinergic and adenosinergic systems on the branchial immune response of experimentally infected silver catfish with Streptococcus agalactiae.

It has been recognized that the cholinergic and adenosinergic systems have an essential role in immune and inflammatory responses during bacterial fish pathogens, such as the enzymes acetylcholinesterase (AChE) and adenosine deaminase (ADA), which are responsible for catalysis of the anti-inflammatory molecules acetylcholine (ACh) and adenosine (Ado) respectively. Thus, the aim of this study was to investigate the involvement of the cholinergic and adenosinergic systems on the immune response and inflammatory process in gills of experimentally infected Rhamdia quelen with Streptococcus agalactiae. Acetylcholinesterase activity decreased, while ACh levels increased in gills of infected animals compared to uninfected animals. On the other hand, a significant increase in ADA activity with a concomitant decrease in Ado levels was observed in infected animals compared to uninfected animals. Based on this evidence, we concluded that infection by S. agalactiae in silver catfish alters the cholinergic and adenosinergic systems, suggesting the involvement of AChE and ADA activities on immune and inflammatory responses, regulating the ACh and Ado levels. In summary, the downregulation of AChE activity exerts an anti-inflammatory profile in an attempt to reduce or prevent the tissue damage, while the upregulation of ADA activity exerts a pro-inflammatory profile, contributing to disease pathophysiology.

Placental transfer of IgG antibodies specific to Klebsiella and Pseudomonas LPS and to group B Streptococcus in twin pregnancies.

Group B Streptococcus (GBS), Klebsiella spp. and Pseudomonas spp. are important aetiological agents of neonatal infections in Brazil. There is a lack of data in the literature regarding the specific transport of immunoglobulin G (IgG) against these pathogens in multiple pregnancies. Maternal (n = 55) and umbilical cord (n = 110) blood samples were prospectively collected at birth from 55 twin pregnancies. The factors associated with cord levels and transfer ratios of IgG against GBS, Klebsiella and Pseudomonas were examined. The IgG umbilical cord serum levels specific to GBS, Klebsiella LPS and Pseudomonas LPS were significantly associated with maternal-specific IgG concentrations and the presence of diabetes. The anti-Klebsiella IgG cord serum concentrations were also related to birthweight and the presence of hypertension. The transfer ratios against GBS and Pseudomonas LPS were associated with maternal-specific IgG concentrations. The transfer ratios for GBS and Pseudomonas LPS were associated with gestational age at delivery and the presence of diabetes, respectively. None of the examined parameters were related to Klebsiella LPS transfer ratios. We conclude that in twin pregnancies, specific maternal IgG serum concentrations and diabetes were the parameters associated with umbilical cord serum IgG concentrations reactive with the three pathogens investigated. All the other parameters investigated showed different associations with neonatal-specific IgG levels according to the antigen studied. There was no uniformity of the investigated parameters regarding association with placental IgG transfer ratios against the GBS, Pseudomonas LPS and Klebsiella LPS.

Acute aerocystitis in Nile tilapia bred in net cages and supplemented with chromium carbochelate and Saccharomyces cerevisiae.

Oreochromis niloticus bred in net cages were supplemented with cell wall of Saccharomyces cerevisiae (Sc) (0.3%) or chromium carbochelate (Cr) (18 mg/kg of feed) or in association (Sc + Cr), for 90 days. After this period, acute inflammation was induced in the swim bladder by inoculation of 3 × 10(8) CFU of inactivated Streptococcus agalactiae, and another group received 0.65% saline solution (control). Twelve, 24, and 48 h after stimulation, the inflammation was evaluated through total and differential counting of accumulated cells, and through leukocyte respiratory burst in the blood, cortisolemia, glycemia and serum lysozyme concentration. The results showed that there were greater total numbers of cells in the exudate of fish inoculated with inactivated bacterium than in those injected with saline solution, with predominance of lymphocytes, thrombocytes, macrophages and granulocytes. Tilapia supplemented with Cr presented increased total numbers of cells with significant accumulation of lymphocytes and reductions in cortisolemia and glycemia, but the different treatments did not have any influence on leukocyte respiratory burst or serum lysozyme concentration. Tilapia supplemented with Sc and the Cr + Sc association did not present significant changes to the variables evaluated, despite higher accumulation of lymphocytes in the inflammatory exudate from fish treated with Sc. The results indicate that tilapia bred in net cages and supplemented with Cr presented higher total accumulation of cells at the inflammatory focus, thus indicating an increase in the inflammatory response induced by the bacterium, probably due to the reduction in cortisolemia and higher glucose consumption. Thus, supplementation with Cr had beneficial action, which facilitated development of acute inflammation induced by the bacterium, but did not affect neither leukocyte respiratory burst in the blood nor serum lysozyme concentration.

In silico prediction of conserved vaccine targets in Streptococcus agalactiae strains isolated from fish, cattle, and human samples.

Streptococcus agalactiae (Lancefield group B; group B streptococci) is a major pathogen that causes meningoencephalitis in fish, mastitis in cows, and neonatal sepsis and meningitis in humans. The available prophylactic measures for conserving human and animal health are not totally effective and have limitations. Effective vaccines against the different serotypes or genotypes of pathogenic strains from the various hosts would be useful. We used an in silico strategy to identify conserved vaccine candidates in 15 genomes of group B streptococci strains isolated from human, bovine, and fish samples. The degree of conservation, subcellular localization, and immunogenic potential of S. agalactiae proteins were investigated. We identified 36 antigenic proteins that were conserved in all 15 genomes. Among these proteins, 5 and 23 were shared only by human or fish strains, respectively. These potential vaccine targets may help develop effective vaccines that will help prevent S. agalactiae infection.

Evidence of in vitro differential secretion of human beta-defensins-1, -2, and -3 after selective exposure to Streptococcus agalactiae in human fetal membranes.

OBJECTIVE: The aim of this work was to characterize the individual contribution of the amnion (AMN) and choriodecidua (CHD) regions to the secretion of human beta defensins (HBD)-1, -2, and -3, after stimulation with Streptococcus agalactiae. METHODS: Full-thickness membranes were mounted on a Transwell device, constituted by two independent chambers; 1 × 10(6) CFU/ml of S. agalactiae were added to either the AMN or CHD face or to both. Secretion profiles of HBD-1, HBD-2, and HBD-3 to the culture medium were quantified by enzyme-linked immunosorbent sandwich assay (ELISA). RESULTS: Secretion profile of HBD-1 remained without significant changes; HBD-2 secretion level by the CHD increased 2.0 (2.73 ± 0.19 pg/µg) and 2.6 (3.62 ± 0.60 pg/µg) times when the stimulus was applied only to the CHD region and simultaneously to both compartments, respectively. The bacterial stimulation in the AMN induced a 2.0 times (2.06 ± 0.29 pg/µg) increase in this region. HBD-3 secretion level increased significantly in the CHD (15.65 ± 2.68 pg/µg) and the AMN (14.94 ± 1.85 pg/µg) only when both regions were stimulated simultaneously. CONCLUSION: The stimulation of human fetal membranes with S. agalactiae induced a differential and tissue-specific profile of HBD-1, HBD-2, and HBD-3 secretion.

Aspects of the natural history and virulence of S. agalactiae infection in Nile tilapia.

Streptococcus agalactiae is an emerging pathogen in Nile tilapia (Oreochromis niloticus) worldwide. To investigate aspects of the epidemiology, transmission and virulence of S. agalactiae infections, nine outbreaks of meningoencephalitis and septicemia in Nile tilapia farms in Brazil were analyzed. Records from the outbreaks revealed large variation in the weight of fish affected, high mortality, and disease occurrence at water temperatures above 26 degrees C. S. agalactiae was isolated from diseased fish from all farms, and 29 strains were identified by phenotypic tests and 16S rRNA gene sequencing. Five strains from different geographic origins were selected to determine the 50% lethal dose (LD(50)). All strains were highly virulent; for example, strain SA 20-06 had an LD(50) of 90 bacteria. To investigate S. agalactiae transmission, we conducted cohabitation assays with diseased and healthy fish and fish challenges using an immersion bath or gill inoculation. Strain SA 20-06 was used in all assays. The disease was reproduced with characteristic clinical signs and S. agalactiae was reisolated in all trials. The infection route studies were identified as by direct contact or through the water. In conclusion, S. agalactiae, a major pathogen of Nile tilapia in Brazil, exhibited high virulence, regardless of the geographic origin of the isolated strains.

Profilaxis de sepsis neonatal por Streptococcus Agalactiae (grupo B) basada en vacunas: revisión de la literatura / Prophylaxis of early neonatal sepsis Streptococcus Agalactiae (group B) based on vaccines: literature review

El Streptococcus agalactiae o grupo B (SGB), es el principal agente de sepsis neonatal precoz. A pesar de los intentos de prevención de esta infección, aún no se logra la efectividad esperada. Es por esto que se ha intentado desarrollar una vacuna que pueda prevenir la mayoría de las patologías que esta bacteria produce, incluyendo la sepsis neonatal precoz y tardía. De esta manera se evitarían las limitaciones actuales de la profilaxis antibiótica. Los intentos de crear una vacuna han incluido la utilización de polisacáridos del SGB tanto puros como asociados a proteínas como el toxoide tetánico. También, se han usado proteínas específicas de la cápsula que tienen potencial efectividad como factores inmunogénicos. Las vacunas conjugadas son las más estudiadas en la actualidad, habiendo completado estudios clínicos en fase II, tanto en adultos sanos como en embarazadas. Al ser la sepsis neonatal una complicación grave aún no controlada óptimamente, la creación de una vacuna contra este patógeno sería de gran impacto en salud pública. Se presentan los diferentes tipos de vacunas desarrolladas y el estado de avance en el que se encuentran.

Streptococcus agalactiae or group B, is the mayor causing agent of early onset neonatal sepsis. Although mayor prevention strategies have been made, the expected effectiveness hasn't been achieved. That's why efforts have been made to develop a vaccine that can prevent most of the diseases these bacteria can produce, including early and late onset neonatal sepsis. These way, actual antibiotic prophylaxis limitations can be avoided. Attempts include the utilization of Streptococcus group B polysaccharides in their pure state or combined with proteins as tetanic toxoid. Specific capsule proteins have been used also because of their potential effectiveness as inmunogenic factors. Overall vaccines conjugated ones are the most studied, having completed phase II clinical trials in healthy adults and pregnant women. Neonatal sepsis is a severe complication that has not been controlled yet, so the creation of a vaccine against this pathogen would be of great impact in public health. We introduce now the different developed vaccines and their state of progress.

Vacinas em desenvolvimento: estreptococo do grupo B, herpes-zóster, HIV, malária e dengue / Vaccines under development: group B streptococcus, herpes-zoster, HIV, malaria and dengue

OBJETIVOS: As vacinas contra o estreptococo B, o herpes-zóster, o HIV, a malária e a dengue, selecionadas por critérios de comercialização iminente ou devido a problemas específicos para sua obtenção, foram objeto de uma revisão sobre o estado atual do seu desenvolvimento. FONTE DOS DADOS:Foi realizada revisão da literatura através da MEDLINE no período de 1996 a 2006, sobre a epidemiologia e imunologia das doenças, analisando tanto os maiores problemas para a obtenção de uma vacina como o estado atual dos estudos, com ênfase para os que estavam em fase mais adiantada. SíNTESE DOS DADOS: Cada uma das cinco doenças escolhidas apresenta problemas específicos para o desenvolvimento de uma vacina. No entanto, a maioria deles já foi ou está em vias de ser resolvido, permitindo prever que uma vacina - ou vacinas - eficaz e segura estará disponível em futuro próximo. CONCLUSÕES:Apesar dos problemas enfrentados para o desenvolvimento dessas vacinas, os avanços da biologia molecular e da imunologia permitiram superar a maioria deles, abrindo a perspectiva para a obtenção de novas vacinas.

Vaccines under development: group B streptococcus, herpes-zoster, HIV, malaria and dengue.

OBJECTIVES: To review the current state of development of streptococcus B, herpes-zoster, HIV, malaria and dengue vaccines. These vaccines were selected both because of imminent commercial release and because of specific problems with their development. SOURCES OF DATA: A review of the literature was performed by means of a MEDLINE search, on the period 1996 to 2006, for the epidemiology and immunology of these diseases, analyzing both the greatest obstacles to creating a vaccine and the current state of research, with emphasis on studies in the most advanced stages. SUMMARY OF THE FINDINGS: Each of the five diseases chosen presents specific problems for vaccine development. Nevertheless, in the majority of cases these have been or are in sight of being resolved, allowing for the prediction that a safe and effective vaccine - or vaccines - will be available in the near future. CONCLUSIONS: Despite the problems faced in developing these vaccines, advances in molecular biology and immunology have made it possible to overcome most obstacles, opening up the prospects for new vaccines.